Replies to post #55806 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I contend it was likely sufficiently enrolled, LP stated it was very close to complete enrollment according to someone's notes. Or did you forget about that. I think that is the conclusion Drummword just drew as well based upon his discussion with Les. The process was wise to use a partial screening halt at that time because if need be, they can reopen enrollment for either an expansion, if necessary (again precaution), or for confirmatory enrollment if the same trial is converted to a confirmatory trial.

[VMLG17]

In all seriousness, can you provide just one example of a company that had such success in treating cancer patients with technology that "unblocks and re-establishes the flow of (tumor) signals through delivery of a fresh set of newly matured, activated and educated dendritic cells, which the tumor has not had a chance to paralyze or impair to block the flow of signals"?